Bullfrog Ai Holdings, INC 8-K filings

NASDAQ
BullFrog AI Holdings, Inc. has announced the addition of two distinguished scientific advisors, Dr. Gwenn Smith and Dr. Jeremiah Wala, to its advisory board.
NASDAQ
BullFrog AI and the Lieber Institute for Brain Development have announced early results from their collaboration, successfully stratifying brain expression data and potentially revolutionizing the understanding of psychiatric disorders.
NASDAQ
BullFrog AI has been granted an Australian patent for its novel prodrugs of mebendazole, aimed at improving cancer treatment.